Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,042 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,672 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07264088 | Identifying the Best Follow up Approach for People Who Have Had Treatment to Cure Newly Diagnosed Prostate Cancer(FOLLOW-UP) | not yet recruiting | — | 100,000 | Imperial College LondonOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT07475533 | Low-flow Versus Minimal-flow Sevoflurane Anesthesia During Robot-assisted Laparoscopic Radical Prostatectomy | not yet recruiting | N/A | 70 | Ankara City Hospital BilkentOTHER | 0 | Apr 15, 2026 |
| clinicaltrials |
| NCT07532148 | Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | not yet recruiting | Phase 1 | 24 | Chong Kun Dang PharmaceuticalINDUSTRY | 0 | Apr 15, 2026 | clinicaltrials |
| NCT07529418 | The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS Study(BALANCE) | not yet recruiting | — | 800 | Institute of Cancer Research, United KingdomOTHER | 0 | Apr 14, 2026 | clinicaltrials |
| NCT07522697 | Inavolisib for PIK3CA Mutated Advanced Endometrial Cancer: MITO END-4(MITO END-4) | not yet recruiting | Phase 2 | 48 | National Cancer Institute, NaplesOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT07523152 | Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With HPV-positive Pelvic Cancer: a Descriptive Longitudinal Study(SAPPHIRE) | not yet recruiting | N/A | 42 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 0 | Apr 13, 2026 | clinicaltrials |
| NCT07189702 | Plant-Based Nutrition for Breast or Endometrial Cancer(BEND-MBEC) | not yet recruiting | N/A | 60 | University of RochesterOTHER | 0 | Apr 8, 2026 | clinicaltrials |
| NCT07516704 | Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate Cancer: A Multicenter Prospective, Single-Arm Clinical Study | not yet recruiting | Early Phase 1 | 94 | Zhongda HospitalOTHER | 0 | Apr 8, 2026 | clinicaltrials |
| NCT07516808 | PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy | not yet recruiting | N/A | 20 | Beth Israel Deaconess Medical CenterOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT07492381 | A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate Cancer | not yet recruiting | N/A | 50 | ALPFA MedicalINDUSTRY | 0 | Apr 7, 2026 | clinicaltrials |
| NCT07514325 | MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer(MASTEC) | not yet recruiting | N/A | 61 | Radboud University Medical CenterOTHER | 0 | Apr 7, 2026 | clinicaltrials |
| NCT07516210 | Adaptive Radiotherapy for Safe Hypofractionation(ART-Hypo) | not yet recruiting | Phase 2 | 264 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Apr 7, 2026 | clinicaltrials |
| NCT07290998 | Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Recurrent Prostate Cancer | not yet recruiting | N/A | 12 | Alpha Tau Medical LTD.INDUSTRY | 0 | Apr 6, 2026 | clinicaltrials |
| NCT07512973 | Single-channel Fibroid Morcellation System Used in Clinical Research on Laparoscopic Myomectomy | not yet recruiting | N/A | 78 | First People's Hospital of HangzhouOTHER | 0 | Apr 6, 2026 | clinicaltrials |
| NCT07501676 | Transmucosal Uterosacral Electrical Stimulation for Pelvic Pain Relief(TUNES) | not yet recruiting | N/A | 60 | Weill Medical College of Cornell UniversityOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT07497074 | JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer | not yet recruiting | Phase 2 | 78 | Jiangsu Alphamab Biopharmaceuticals Co., LtdINDUSTRY | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07497802 | Mindfulness-Based Psychoeducation for Women With Gynecological Cancer(MIND-GYN) | not yet recruiting | N/A | 96 | Ondokuz Mayıs UniversityOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT06476639 | A Phase III Randomised Clinical Trial of Ultrasound Groin Monitoring Versus Groin Lymph Node Dissection to De-Escalate the Extent of Surgery in Vulvar Cancer(ANVU) | not yet recruiting | Phase 3 | 640 | Queensland Centre for Gynaecological CancerOTHER_GOV | 1 | Mar 24, 2026 | clinicaltrials |
| NCT07489300 | Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal Cancer(BACON) | not yet recruiting | Phase 2 | 40 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 0 | Mar 24, 2026 | clinicaltrials |
| NCT07484269 | PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan(PULSE) | not yet recruiting | — | 753 | Novartis PharmaceuticalsINDUSTRY | 0 | Mar 20, 2026 | clinicaltrials |
| NCT07485881 | 18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients | not yet recruiting | — | 59 | Assiut UniversityOTHER | 0 | Mar 20, 2026 | clinicaltrials |
| NCT07483905 | Interest in Nighttime Day Hospital Chemotherapy Infusions Among Gynecologic Cancer Patients(CHeMoON) | not yet recruiting | — | 200 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT07145437 | Prostate Stereotactic Radiation and Radio-induced Lymphocyte Apoptosis for Predicting Late Toxicities in Prostate Cancer (PROSTERA)(PROSTERA) | not yet recruiting | N/A | 220 | Clinique Sainte ClotildeOTHER | 0 | Mar 18, 2026 | clinicaltrials |
| NCT07480044 | A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery | not yet recruiting | N/A | 220 | Zhejiang UniversityOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT07476677 | Darolutamide ± ADT as Neoadjuvant Therapy in High-Risk/Very High-Risk Localized Prostate Cancer(ANDARP) | not yet recruiting | Phase 2 | 60 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT05479045 | A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients | not yet recruiting | Phase 2 | 24 | Georgetown UniversityOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT07455071 | A Single-center, Dose-escalation Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Tumor Neoantigen-pulsed Autologous Dendritic Cell Injection (YS247) in Study Participants With HRD-negative Epithelial Ovarian Cancer(YS247) | not yet recruiting | N/A | 9 | Peking University Third HospitalOTHER | 0 | Mar 16, 2026 | clinicaltrials |
| NCT07468838 | Feasibility Study of Urinary cfDNA Analysis as a Non-invasive Monitoring Tool in Patients With Prostate or Bladder Cancer(UroDNA) | not yet recruiting | — | 25 | Institut Cancerologie de l'OuestOTHER | 0 | Mar 16, 2026 | clinicaltrials |
| NCT07462468 | A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer. | not yet recruiting | Phase 1 | 36 | WestVac Biopharma Co., Ltd.INDUSTRY | 0 | Mar 13, 2026 | clinicaltrials |
| NCT07457164 | A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer | not yet recruiting | Phase 2 | 40 | Antev Ltd.INDUSTRY | 0 | Mar 12, 2026 | clinicaltrials |
| NCT07466901 | A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy After Radical Resection of Cervical Cancer | not yet recruiting | N/A | 30 | Jin LIOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT07468396 | A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer | not yet recruiting | Phase 1 | 65 | Gan & Lee Pharmaceuticals.INDUSTRY | 1 | Mar 12, 2026 | clinicaltrials |
| NCT07460726 | PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate Cancer(PRIAPUS-PCa) | not yet recruiting | — | 130 | CancerCare ManitobaOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT07461142 | Reduction of Hematologic Toxicity in Locally Advanced Cervical Cancers(RETHEMCOL) | not yet recruiting | N/A | 72 | Institut Paoli-CalmettesOTHER | 0 | Mar 10, 2026 | clinicaltrials |
| NCT07453394 | QLS5132 Combination Therapy in Advanced Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 626 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 0 | Mar 6, 2026 | clinicaltrials |
| NCT07454018 | Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive Recurrent Ovarian Cancer | not yet recruiting | Phase 2 | 45 | The First Affiliated Hospital of Soochow UniversityOTHER | 0 | Mar 6, 2026 | clinicaltrials |
| NCT07450963 | Cadonilimab Combined With RT in LACC Patients Ineligible for CCRT | not yet recruiting | Phase 2 | 45 | Ruijin HospitalOTHER | 0 | Mar 5, 2026 | clinicaltrials |
| NCT07437482 | Cancer Literacy Education and Awareness Resources for Prostate Care(CLEAR-PC) | not yet recruiting | — | 3,100 | Universidad Miguel Hernandez de ElcheOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT07444983 | Rezvilutamide for High-Risk Prostate Cancer After Surgery | not yet recruiting | N/A | 33 | Fujian Medical University Union HospitalOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT07437326 | Food-related Quality of Life in Patients With Cancer(QVA-Mod) | not yet recruiting | — | 180 | Hospices Civils de LyonOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07440641 | RE-FIT (Remote Exercise for Physical Function in WTC Responders With Prostate Cancer)(RE-FIT) | not yet recruiting | N/A | 40 | University of VermontOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07432594 | Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer | not yet recruiting | Phase 2 | 82 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 0 | Feb 25, 2026 | clinicaltrials |
| NCT07429799 | An Exploratory Study of Detection of Endometrial and Ovarian Cancers in Vaginal Samples Retrieved by the Ellele Sampling Device | not yet recruiting | N/A | 300 | Ellele HealthINDUSTRY | 0 | Feb 24, 2026 | clinicaltrials |
| NCT07389239 | A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies. | not yet recruiting | Phase 1 / Phase 2 | 24 | University of ChicagoOTHER | 1 | Feb 20, 2026 | clinicaltrials |
| NCT07423117 | A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy | not yet recruiting | Phase 1 | 102 | IntoCell, IncINDUSTRY | 0 | Feb 20, 2026 | clinicaltrials |
| NCT07420010 | An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors. | not yet recruiting | Early Phase 1 | 24 | Weijia Fang, MDOTHER | 0 | Feb 19, 2026 | clinicaltrials |
| NCT07332832 | Sequential bpMRI for Suspicious Prostate Lesions(SEQ-bpMRI) | not yet recruiting | — | 1,000 | Peking University First HospitalOTHER | 0 | Feb 18, 2026 | clinicaltrials |
| NCT06900582 | SENTInel Node Mapping Versus Comprehensive Lymphadenectomy in p53-Mutated Endometrial Cancer: A Non-Inferiority Randomized Trial(SENTIMETREP53) | not yet recruiting | N/A | 374 | University Hospital, Strasbourg, FranceOTHER | 0 | Feb 17, 2026 | clinicaltrials |
| NCT07412873 | Study on Sexual Health and Self-perceived Quality of Life (PROMs) in Patients Treated for Cervical Cancer(PROVIDENCE) | not yet recruiting | Phase 4 | 120 | Fundacion Clinic per a la Recerca BiomédicaOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07406789 | Phase II, Prospective, Randomized, Proof-of-concept Study to Evaluate the Effects of a Personalized Dietary Intervention in Women With Advanced Gynecologic or Breast Tumors Treated With Antibody-Drug Conjugates (ADCs).(LUMInova) | not yet recruiting | Phase 2 | 100 | TNC Nutrición Terapéutica S.L.OTHER | 1 | Feb 12, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Apr 16, 2026source: clinicaltrials